Request for Proposals (RFP) No. N01DA-6-7758 Synthesis and Distribution of Opioid and Related Peptides

Notice Number: NOT-DA-06-020

Key Dates
Release Date: February 10, 2006

Issued by
National Institute on Drug Abuse (NIDA), (http://www.nida.nih.gov)

The National Institute on Drug Abuse plans to procure services from a qualified organization having the capability to produce, store, and distribute labeled and unlabeled opioid peptides and related neuropeptides. These may include, but are not limited to, unlabeled, tritum or I-125 labeled opioid peptides, and related compounds. Qualified organizations must be able to check the stability and purity of the compounds, maintain and store the compound inventory under secure conditions, and distribute the compounds to research investigators. In order to meet the demand for authentic, pure, and racemization free peptides, NIDA will require the contractor to maintain an inventory of approximately 40-45 peptides and some of their respective radio labeled compounds (approximately 23-25) and supply them primarily to NIDA grantees for use in NIDA supported studies and at the same time maintain capability to rapidly synthesize, on demand, new peptides that are potentially useful in drug abuse research. NIDA expects to award a 5-year contract. RFP No. N01DA-6-7758 will be available electronically on or about February 16, 2006 and may be accessed through the Internet at: http://www.fedbizopps.gov or through the NIDA website address: http://www.nida.nih.gov/RFP/RFPList.html. The electronic RFP contains all information needed to submit an offer. No printed version of the solicitation document or source list is available. NIDA will consider proposals submitted by any responsible offeror. Proposals will be due on or about April 14, 2006 . Following proposal submission and the initial review, the Contracting Officer may require additional documentation from offerors in the competitive range. This advertisement does not commit the Government to award a contract. This solicitation is not a commercial acquisition.

Point of Contact:

Diane M. Loeb, Contract Specialist
NIDA R & D Contracts Management Branch, OPRM
Neuroscience Office of Acquisitions
National Institute on Drug Abuse, NIH
6101 Executive Boulevard
Room 260, MSC 8402
Bethesda , Maryland 20892-8402
Email: dl294p@nih.gov
Telephone: (301) 443-6677
Fax: (301) 443-7595